JP Morgan Healthcare Conference, Day 2: Thermo Fisher Scientific, Qiagen, Gen-Probe, Exact Sciences | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated from a previous version to correct the specificity of Exact Sciences test. The specificity was 91 percent, not 81 percent as originally reported.

SAN FRANCISCO (GenomeWeb News) – The second day of the JP Morgan Healthcare Conference included several of the best-known names in the genomics space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.